Does Vascular Endothelial Growth Factor Gene Therapy Safely Improve Outcome in Severe Early-Onset Fetal Growth Restriction? (EVERREST).

@article{2015DoesVE,
  title={Does Vascular Endothelial Growth Factor Gene Therapy Safely Improve Outcome in Severe Early-Onset Fetal Growth Restriction? (EVERREST).},
  author={},
  journal={Human gene therapy. Clinical development},
  year={2015},
  volume={26 2},
  pages={82-4}
}
men is open, and four patients have been already recruited. Validation of preclinical gene therapy studies with the therapeutic clinical-grade LV: A clinical lot of the FANCALV has been already produced. The batch is used for the validation of the transduction protocol under GMP conditions, as well as for the validation of all the quality controls required… CONTINUE READING